TW200701983A - Novel use of peptide compounds for treating dyskinesia - Google Patents

Novel use of peptide compounds for treating dyskinesia

Info

Publication number
TW200701983A
TW200701983A TW094123422A TW94123422A TW200701983A TW 200701983 A TW200701983 A TW 200701983A TW 094123422 A TW094123422 A TW 094123422A TW 94123422 A TW94123422 A TW 94123422A TW 200701983 A TW200701983 A TW 200701983A
Authority
TW
Taiwan
Prior art keywords
peptide compounds
novel use
treating dyskinesia
treating
dyskinesia
Prior art date
Application number
TW094123422A
Other languages
Chinese (zh)
Inventor
Thomas Stohr
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04011833A external-priority patent/EP1604654A1/en
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of TW200701983A publication Critical patent/TW200701983A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention is directed to the use of a class of peptide compounds for treating primary or/and secondary dyskinesias such as tardive dyskinesia.
TW094123422A 2004-05-18 2005-07-11 Novel use of peptide compounds for treating dyskinesia TW200701983A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57193204P 2004-05-18 2004-05-18
EP04011833A EP1604654A1 (en) 2004-05-18 2004-05-18 Novel use of peptide compounds for treating dyskinesia

Publications (1)

Publication Number Publication Date
TW200701983A true TW200701983A (en) 2007-01-16

Family

ID=34969829

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094123422A TW200701983A (en) 2004-05-18 2005-07-11 Novel use of peptide compounds for treating dyskinesia

Country Status (4)

Country Link
KR (1) KR20070010168A (en)
IL (1) IL179072A0 (en)
NO (1) NO20065829L (en)
TW (1) TW200701983A (en)

Also Published As

Publication number Publication date
NO20065829L (en) 2007-01-25
IL179072A0 (en) 2008-03-20
KR20070010168A (en) 2007-01-22

Similar Documents

Publication Publication Date Title
UA86808C2 (en) Novel use of peptide compounds for treating dyskinesia
UA88166C2 (en) Use of peptide compounds for treating essential tremor and other tremor syndromes
MX2008002293A (en) Novel use of peptide compounds for treating muscle pain.
TW200701982A (en) Novel use of peptide compounds for treating pain in trigeminal neuralgia
TW200640924A (en) VEGF-R2 inhibitors and methods
SI1761520T1 (en) Kinase inhibitors
MX2008007808A (en) Rifamycin analogs and uses thereof.
TW200602029A (en) Inhibitors of IAP
TW200719892A (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
IL161966A0 (en) Aryloxyphenyl and arylsulfanylphenyl
ZA200701137B (en) Triazolophthalazines
MX2007008137A (en) Triazolophthalazines.
EA200700702A1 (en) LOKSAPINA ANALOGUES AND METHODS OF THEIR APPLICATION
TW200630367A (en) Substituted adenines and the uses thereof
UA85505C2 (en) Kinase inhibitors
CL2007002384A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the treatment of psoriasis.
IL163777A0 (en) Kinase inhibitors
CL2007002380A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the therapeutic and / or prophylactic treatment of actinic keratosis.
BRPI0514672A (en) fusobacterium polypeptides and methods of use
TW200738244A (en) 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof
DE602004012146D1 (en) Pyrazolopyrimidine
TW200621718A (en) Novel co-crystals
TW200701983A (en) Novel use of peptide compounds for treating dyskinesia
MY139442A (en) Novel use of peptide compounds for treating dyskinesia
LT2003075A (en) Inhibitor of monoamine uptake